Drug Trial Radar · NCT07594847
A Study of HDM1002 Tablets on Cardiac Repolarization in Healthy Subjects
Last checked: Nov 19, 2026Latest source record: May 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
72
Planned (sponsor's estimate)
Start
Mar 7, 2026
Primary completion
Sep 25, 2026
Study completion Nov 6, 2026
Sponsor
- Lead sponsor
- Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- May 19, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 45 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The aim of this trial is to evaluate the effect of a single oral dose of HDM1002 tablets on the QT/QTc interval in healthy subjects.
Conditions
- Healthy Adult Subject
Interventions
HDM1002 200 mgDrug
HDM1002 tablet, oral, 200 mg single dose
HDM1002 400 mgDrug
HDM1002 tablet, oral, 400 mg single dose
PlaceboDrug
Placebo tablet, oral, single dose
Moxifloxacin 400 mgDrug
Moxifloxacin tablet, oral, 400 mg single dose
Primary outcomes
What the sponsor says the trial is designed to measure.
- Correlation between HDM1002 Plasma Concentration and ΔΔQTcTime frame: From the base line ECG (Day -1) to end of the period, up to 48 hours post-dose
Locations
1 site in 1 country. Site status is shown where the registry gives one.
PKUcare Luzhong Hospital
Zibo, Shangdong, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.